Novel polymorphisms of the human cholecystokinin A receptor gene: An association analysis with schizophrenia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 96, Issue 2, 2000, Pages 141-145

  Tachikawa, Hirokazu ^a   Harada, Shoji ^a   Kawanishi, Yoichi ^a   Okubo, Takehito ^a   Shiraishi, Hiroyasu ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Association analysis; CCK AR gene; Polymorphism; Schizophrenia

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; DOPAMINE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE MAPPING; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SEQUENCE ANALYSIS;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; SCHIZOPHRENIA;

EID: 0034599607     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000403)96:2<141::AID-AJMG3>3.0.CO;2-R     Document Type: Article

References (24)

1. Altar CA, Boyar WC. 1989. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin. Brain Res 483:321-326.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, p 273-315.
3. Asherson P, Mant R, Williams N, et al. 1998. A study on chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Mol Psychiatry 3:310-320.
4. Blackwood DH, He L, Morris SW, et al. 1996. A locus for bipolar affective disorder on chromosome 4p. Nat Genet 12:427-430.
5. Bowen T, Norton N, Jacobsen NJO, et al. 1998. Linked polymorphisms upstream of exons 1 and 2 of the human cholecystokinin gene are not associated with schizophrenia or bipolar disorder. Mol Psychiatry 3: 67-71.
6. Bucher P. 1990. Weight matrix descriptions of four eukaryotic RNA polymorphase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol 212:563-578.
7. Chen WJ, Lu ML, Hsu YPP, Chen CC, Yu JM, Cheng ATA. 1997. Dopamine D2 receptor gene and alcoholism among four aboriginal groups and Han in Taiwan. Am J Med Genet 74:129-136.
8. Cohen J. 1977. Statistical power analysis for the behavioral sciences. New York: Academic Press. p 215-271.
9. Crawley JN, Corwin RL. 1994. Biological actions of cholecystokinin. Peptides 15:731-755.
10. De Weerth A, Pisegna JR, Huppi K, Wank SA. 1993. Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem Biophys Res Commun 194:811-818.
11. Ginna EI, Jean PS, Philibert RA, et al. 1998. A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish. Proc Natl Acad Sci 95:15531-15536.
12. 3H-MK-329. J Neurosci 10:1070-1081.
13. Huppi K, Siwarski D, Pisegna JR, Wank S. 1995. Chromosomal localization of the gastric and brain receptors for cholecystokinin (CCKAR and CCKBR) in human and mouse. Genomics 25:727-729.
14. Inoue H, Iannotti CA, Welling CM, Veile R, Donis-Keller H, Permutt MA. 1997. Human cholecystokinin type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM). Genomics 42:331-335.
15. 1A receptor gene and association analysis in schizophrenia. Am J Med Genet 81:434-439.
16. Marshall FH, Barnes S, Hughes J, Woodruff GN, Hunter JC. 1991. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. J Neurochem 56:917-922.
17. Merika M, Orkin SH. 1993. DNA-binding specificity of GATA family transcription factors. Mol Cell Biol 13:3999-4010.
18. Miller JR, Holicky EL, Ulrich CD, Wieben ED. 1995. Abnormal processing of the human cholecytokinin receptor gene in association with gallstone and obesity. Gastroenterology 109:1375-1380.
19. Moran TH, Robinson P, Goldrich MS, McHugh PR. 1986. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res 362:175-179.
20. Shapiro MB, Senepathy P. 1987. RNA splice junctions of different classes of eukaryocytes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155-7174.
21. Tachikawa H, Harada S, Kawanishi Y, Okubo T, Shiraishi H. 1999. Novel polymorphism in the promoter and coding regions of the human choiecystokinin B receptor gene: an association analysis with schizophrenia. Am J Med Genet 88:700-704.
22. Terwillinger JD, Otto J. 1994. Handbook of human genetic linkage. Baltimore: John Hopkins University Press.
23. Uirich CD, Ferber I, Holicky E, Hadac E, Buell G, Miller LJ. 1993. Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor. Biochem Biophys Res Commun 193:204-211.
24. 3H]-dopamine efflux from rat nucleus accumbens. Neuropeptides 13:43-50.